Spread the Word about the TAK-573-1501 Trial

Do you have a friend or family member with relapsed or refractory multiple myeloma (RRMM) who may be interested in this clinical research trial? Enter their email address below to send them a link to this website.

Step 1 of 2

Email addresses are not used for any other purpose.
*Indicates required field.

Facing the Facts about Relapsed or Refractory Multiple Myeloma (RRMM)

To help increase awareness of RRMM, we encourage you to share these stats with your friends and family.

While African Americans make up 20% of the people living with myeloma in the US, they only account for 6% of all patients in clinical trials.
The National Cancer Institute estimates 34,920 new cases of myeloma may be diagnosed in the US.